Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of our study was to assess serum endocan levels in patients with Behcet disease and to correlate it with various disease clinical and laboratory parameters of disease activity as well as carotid intima media thickness.
This study will be carried out on two groups:
• Group (I): Forty two patients diagnosed to have Behcets disease fulfilling the International Criteria for BD .
Group (II): including 42 age and sex matching healthy volunteers as control group.
(A) Clinical evaluation
All patients will be subjected to the following measurements:
d) Serum Endocan level e)triglycrides f) cholestrol C) carotid intima media thickness
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Behçet group | Forty two patients diagnosed to have Behçet disease fulfilling the International Study Group Criteria for Behçet disease in whom measurement of serum endocan levels will be performed. |
| |
| control group | including 42 age and sex matching healthy volunteers as control group in whom measurement of serum endocan levels will be performed. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| measurement of serum endocan | Diagnostic Test | measurement of serum levels of endocan |
|
| Measure | Description | Time Frame |
|---|---|---|
| the Behcet's disease current activity form (BDCAF) | One point is given to the presence of different organ involvement over the 4 weeks prior to assessment as follows: headache, mouth ulcers, genital ulcers, skin lesions , joint involvement , gastrointestinal symptoms , eye involvement , nervous system involvement , and major vessel involvement.The total score will be out of 12 and higher score indicates worse outcome. we will assess the relation between serum endocan level and BDCAF | : through study completion, an average of 6 months |
| Erythrocyte sedimentation rate (ESR) | ESR measured in mm/1st hour by westergren method. we will assess the relation between serum endocan level and ESR | : through study completion, an average of 6 months |
| C reactive protein (CRP) | CRP measured in mg/L using nephlometry. we will assess the relation between serum endocan level and CRP | : through study completion, an average of 6 months |
| carotid intima media thickness | Color Doppler ultrasonography was performed for both common carotid arteries in a longitudinal orientation and measured with millimeter | : through study completion, an average of 6 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
This study will be carried out on two groups:
• Group (I): Forty two patients diagnosed to have Behcets disease fulfilling the International Criteria for BD .
Group (II): including 42 age and sex matching healthy volunteers as control group.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Waleed Hassan, MD | Benha university- Qaluibya- Egypt | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Benha University Hospital | Banhā | Qalyubia Governorate | 13518 | Egypt |
Not provided
| ID | Term |
|---|---|
| D001528 | Behcet Syndrome |
| ID | Term |
|---|---|
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |
| D014606 | Uveitis, Anterior |
| D015864 | Panuveitis |
Not provided
Not provided
Not provided
Not provided
Not provided
serum samples
| D014605 |
| Uveitis |
| D014603 | Uveal Diseases |
| D005128 | Eye Diseases |
| D014657 | Vasculitis |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D056660 | Hereditary Autoinflammatory Diseases |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D012873 | Skin Diseases, Genetic |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D017445 | Skin Diseases, Vascular |